Barclays has downgraded the following companies:
Boston Scientific BSX from Equal-weight to Underweight, PT lowered from $8 to $7
Medtronic MDT from Overweight to Equal-weight, PT lowered from $46 to $42
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
